These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3413715)
1. Determination of FDP in human plasma by a novel latex immunoassay. Sakai Y; Maeda M; Takei F; Matsumoto T; Nishijima Y; Nakamura K Thromb Res; 1988 May; 50(4):469-79. PubMed ID: 3413715 [TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria]. Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249 [TBL] [Abstract][Full Text] [Related]
3. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads. Greenberg CS; Devine DV; McCrae KM Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576 [TBL] [Abstract][Full Text] [Related]
4. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products. Chen JP; Williams TK; Legendre AM Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573 [TBL] [Abstract][Full Text] [Related]
5. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles. Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646 [TBL] [Abstract][Full Text] [Related]
6. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164 [TBL] [Abstract][Full Text] [Related]
7. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia. Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066 [TBL] [Abstract][Full Text] [Related]
8. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products. Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388 [TBL] [Abstract][Full Text] [Related]
9. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens. Song KS; Kim YA; Kim HK; Park Q Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of a latex agglutination assay for FDP D-dimer to demonstrate the presence of postmortem blood. Sakurada K; Sakai I; Sekiguchi K; Shiraishi T; Ikegaya H; Yoshida K Int J Legal Med; 2005 May; 119(3):167-71. PubMed ID: 15654628 [TBL] [Abstract][Full Text] [Related]
11. Conventional detection method of fibrinogen and fibrin degradation products using latex piezoelectric immunoassay. Aizawa H; Kurosawa S; Tozuka M; Park JW; Kobayashi K; Tanaka H Biosens Bioelectron; 2003 May; 18(5-6):765-71. PubMed ID: 12706590 [TBL] [Abstract][Full Text] [Related]
12. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation. Stokol T; Brooks MB; Erb HN; Mauldin GE Am J Vet Res; 2000 Apr; 61(4):393-8. PubMed ID: 10772103 [TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of the anti-human D-dimer monoclonal antibody 1C9-6F10 to canine fibrin degradation products. Miura N; Furukawa M; Magari Y; Momoi Y J Vet Med Sci; 2013 Jul; 75(7):963-6. PubMed ID: 23420644 [TBL] [Abstract][Full Text] [Related]
14. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique]. Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868 [TBL] [Abstract][Full Text] [Related]
15. Distribution-analyzing latex immunoassay (DALIA): methods for determination of antigen and for elimination of non-specific reaction induced by rheumatoid factor. Sakai Y; Hibino M Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3010-4. PubMed ID: 2632046 [TBL] [Abstract][Full Text] [Related]
17. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products. Wilson JE; Thornton RD Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814 [TBL] [Abstract][Full Text] [Related]
18. Reactivity of D-dimer assays with the fibrinogen--fibrin split products generated by thrombolytic agents. Amiral J; Minard F; Plassart V; Vissac AM; Chambrette B Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):525-30. PubMed ID: 2133230 [TBL] [Abstract][Full Text] [Related]
19. Antigenicity of human fibrinogen and its derivatives. Miura Y Jpn J Med Sci Biol; 1980 Jun; 33(3):145-53. PubMed ID: 6451736 [TBL] [Abstract][Full Text] [Related]
20. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting]. Okumura N; Kagiya H; Saito H; Katsuyama T; Kanai M Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]